BRCA1 and cancer: Each subsequent cycle of chemotherapy not only demethylates more cells at the BRCA1 promoter, but also progressively enriches for these partially methylated cells as the more chemosensitive fully BRCA1 methylated cancer cells are progressively eliminated.